L-DOPA attenuates hyperactivity of Roborovskii hamsters

Yusuke Kabuki, Kazutaka Shigemi, Kousuke Hamasu, Mitsuhiro Furuse

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The Roborovskii hamster (Phodopus roborovskii) has been shown to have high locomotor activity (hyperactivity) and low dopamine concentrations in the brain. We hypothesized that low brain dopamine concentrations play a role in the pathogenesis of hyperactivity. In this study, therefore, we investigated the effects of L-DOPA (L-3,4-dihydroxyphenylalanine), the precursor of dopamine, on the locomotor activity of Roborovskii hamster to verify the above hypothesis. An open field test was employed to measure the locomotor activity. Administration of L-DOPA dose-dependently decreased locomotor activity including distance of path and time spent moving. L-DOPA increased the brain concentration of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid. Concurrently, L-DOPA caused increase of norepinephrine, decrease of serotonin, and atypical alteration of their metabolite concentrations. These findings mainly suggest that in Roborovskii hamsters, a low level of brain dopamine neurotransmission is one of the reasons for hyperactivity, and hyperactivity can be attenuated by L-DOPA.

Original languageEnglish
Pages (from-to)260-264
Number of pages5
JournalBehavioural Pharmacology
Volume20
Issue number3
DOIs
Publication statusPublished - May 1 2009

Fingerprint

Levodopa
Cricetinae
Dopamine
Locomotion
Brain
Phodopus
3,4-Dihydroxyphenylacetic Acid
Synaptic Transmission
Serotonin
Norepinephrine

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Psychiatry and Mental health

Cite this

L-DOPA attenuates hyperactivity of Roborovskii hamsters. / Kabuki, Yusuke; Shigemi, Kazutaka; Hamasu, Kousuke; Furuse, Mitsuhiro.

In: Behavioural Pharmacology, Vol. 20, No. 3, 01.05.2009, p. 260-264.

Research output: Contribution to journalArticle

Kabuki, Yusuke ; Shigemi, Kazutaka ; Hamasu, Kousuke ; Furuse, Mitsuhiro. / L-DOPA attenuates hyperactivity of Roborovskii hamsters. In: Behavioural Pharmacology. 2009 ; Vol. 20, No. 3. pp. 260-264.
@article{fe49b585936d45e5a7e3bcf51c1d4fb2,
title = "L-DOPA attenuates hyperactivity of Roborovskii hamsters",
abstract = "The Roborovskii hamster (Phodopus roborovskii) has been shown to have high locomotor activity (hyperactivity) and low dopamine concentrations in the brain. We hypothesized that low brain dopamine concentrations play a role in the pathogenesis of hyperactivity. In this study, therefore, we investigated the effects of L-DOPA (L-3,4-dihydroxyphenylalanine), the precursor of dopamine, on the locomotor activity of Roborovskii hamster to verify the above hypothesis. An open field test was employed to measure the locomotor activity. Administration of L-DOPA dose-dependently decreased locomotor activity including distance of path and time spent moving. L-DOPA increased the brain concentration of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid. Concurrently, L-DOPA caused increase of norepinephrine, decrease of serotonin, and atypical alteration of their metabolite concentrations. These findings mainly suggest that in Roborovskii hamsters, a low level of brain dopamine neurotransmission is one of the reasons for hyperactivity, and hyperactivity can be attenuated by L-DOPA.",
author = "Yusuke Kabuki and Kazutaka Shigemi and Kousuke Hamasu and Mitsuhiro Furuse",
year = "2009",
month = "5",
day = "1",
doi = "10.1097/FBP.0b013e32832c7111",
language = "English",
volume = "20",
pages = "260--264",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - L-DOPA attenuates hyperactivity of Roborovskii hamsters

AU - Kabuki, Yusuke

AU - Shigemi, Kazutaka

AU - Hamasu, Kousuke

AU - Furuse, Mitsuhiro

PY - 2009/5/1

Y1 - 2009/5/1

N2 - The Roborovskii hamster (Phodopus roborovskii) has been shown to have high locomotor activity (hyperactivity) and low dopamine concentrations in the brain. We hypothesized that low brain dopamine concentrations play a role in the pathogenesis of hyperactivity. In this study, therefore, we investigated the effects of L-DOPA (L-3,4-dihydroxyphenylalanine), the precursor of dopamine, on the locomotor activity of Roborovskii hamster to verify the above hypothesis. An open field test was employed to measure the locomotor activity. Administration of L-DOPA dose-dependently decreased locomotor activity including distance of path and time spent moving. L-DOPA increased the brain concentration of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid. Concurrently, L-DOPA caused increase of norepinephrine, decrease of serotonin, and atypical alteration of their metabolite concentrations. These findings mainly suggest that in Roborovskii hamsters, a low level of brain dopamine neurotransmission is one of the reasons for hyperactivity, and hyperactivity can be attenuated by L-DOPA.

AB - The Roborovskii hamster (Phodopus roborovskii) has been shown to have high locomotor activity (hyperactivity) and low dopamine concentrations in the brain. We hypothesized that low brain dopamine concentrations play a role in the pathogenesis of hyperactivity. In this study, therefore, we investigated the effects of L-DOPA (L-3,4-dihydroxyphenylalanine), the precursor of dopamine, on the locomotor activity of Roborovskii hamster to verify the above hypothesis. An open field test was employed to measure the locomotor activity. Administration of L-DOPA dose-dependently decreased locomotor activity including distance of path and time spent moving. L-DOPA increased the brain concentration of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid. Concurrently, L-DOPA caused increase of norepinephrine, decrease of serotonin, and atypical alteration of their metabolite concentrations. These findings mainly suggest that in Roborovskii hamsters, a low level of brain dopamine neurotransmission is one of the reasons for hyperactivity, and hyperactivity can be attenuated by L-DOPA.

UR - http://www.scopus.com/inward/record.url?scp=67649528694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649528694&partnerID=8YFLogxK

U2 - 10.1097/FBP.0b013e32832c7111

DO - 10.1097/FBP.0b013e32832c7111

M3 - Article

C2 - 19404194

AN - SCOPUS:67649528694

VL - 20

SP - 260

EP - 264

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 3

ER -